2024 HCPCS Code J7668
Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams
TAGS: final milligrams inhalation through administered concentrated metaproterenol
| Short Description | Metaproterenol non-comp con |
| Product Note | 0135 |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | January 01, 2007 |
| HCPCS Code Added Date | January 01, 2000 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J0184 - Inj, amisulpride, 1 mg
- J0185 - Inj., aprepitant, 1 mg
- J0190 - Inj biperiden lactate/5 mg
- J0200 - Alatrofloxacin mesylate
- J0202 - Injection, alemtuzumab
- J0205 - Alglucerase injection
- J0206 - Inj allopurinol sodium 1 mg
- J0207 - Amifostine
- J0208 - Inj, pedmark, 100 mg
- J0209 - Inj, sod thiosulfate (hope)
- J0210 - Methyldopate hcl injection
- J0211 - Inj, nithiodote, 3mg / 125mg
- J0215 - Alefacept
- J0216 - Inj, alfentanil hcl, 500mcg
- J0217 - Inj velmanase alfa-tycv 1 mg
- J0218 - Inj olipudase alfa-rpcp 1mg
- J0219 - Inj aval alfa-nqpt 4mg
- J0220 - Alglucosidase alfa injection
- J0221 - Lumizyme injection
- J0222 - Inj., patisiran, 0.1 mg